Characterization of Aspergillus fumigatus specific CD4 T cell responses.
烟曲霉特异性 CD4 T 细胞反应的表征。
基本信息
- 批准号:7752846
- 负责人:
- 金额:$ 43.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-01 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAdrenal Cortex HormonesAllergicAllergic Bronchopulmonary AspergillosisAllogeneic Bone Marrow TransplantationAlveolar MacrophagesAntigensApplications GrantsAspergillosisAspergillus fumigatusAsthmaBone Marrow TransplantationBreathingCD4 Positive T LymphocytesCell LineCellsComplexCyclophosphamideDiseaseExtrinsic asthmaFungal SporesGenerationsGeneticGerminationGoalsHandHumanHybridomasImmune responseImmune systemImmunocompromised HostImmunologic ReceptorsIndividualInfectionInflammatoryInflammatory ResponseInterferonsInterleukin-10Interleukin-13Interleukin-4LabelLifeLungLung diseasesMediastinalMediatingMoldsMouse StrainsMusMycosesPathogenesisPhenotypePlayPopulationPreventionProcessReceptor CellReproduction sporesRespiratory BurstRoleSignal TransductionT cell responseT-Cell ProliferationT-Cell ReceptorT-LymphocyteTissuesTransforming Growth Factor betaTransgenic Micebasecombatfunctional disabilityfungushuman diseaseimmune activationin vivoinsightkillingsneutrophilnovel therapeutic interventionpathogenpreventresearch studytrafficking
项目摘要
Aspergillus fumigatus is a spore forming mould that causes a range of human diseases, including allergic
bronchopulmonary aspergillosis, an asthma-like disease, and invasive aspergillosis, a frequently fatal
infection that occurs in immunocompromised individuals. Infection by Aspergillus fumigatus results from
inhalation of fungal spores (referred to as conidia), which are taken up by alveolar macrophages and killed by
products of the oxidative burst. Although A. fumigatus-specific T lymphocytes are postulated to play a role in
both allergic and invasive aspergillosis, very little is known about their activation, proliferation, differentiation
and persistence following inhalation of fungal spores. To address this issue, we made CD4 T cell hybridomas
specific for A. fumigatus antigens, cloned the alpha and beta chains of the specific T cell receptor and
generated T cell receptor transgenic mice. Experiments proposed in this grant application will useT cell
receptor transgenic mice to obtain naive, A. fumigatus-specific T cells for transfer and characterization in
infected recipient mice. We have three specific aims. The first is to investigate priming and differentiation of
naTve A. fumigatus-specific T lymphocytes following pulmonary infection with live conidia. The impact ofii_10
and TGF-beta signaling on T cell proliferation and differentiation will be determined. The second aim is to
determine the impact of A. fumigatus-specific CD4 T cells on invasive fungal disease in immunocompromised
or bone marrow transplanted mice. Our third aim is to investigate innate immune responses to fungal spores
and to determine the impact of this process on the differentiation of A. fumigatus-specific CD4 T cells. We will
initially focus on MyD88, Trif and Rip2 mediated signals. These studies will provide a comprehensive picture
of T cell responses to the most prevalent opportunistic fungal pathogen of humans, potentially opening the
door to new therapeutic interventions to combat allergic and invasive fungal diseases.
烟曲霉是一种孢子形成霉菌,可引起一系列人类疾病,包括过敏性疾病
支气管肺曲霉病,一种哮喘样疾病,和侵袭性曲霉病,一种经常致命的
发生在免疫力低下的人身上的感染。烟曲霉感染的原因是
吸入真菌孢子(称为分生孢子),被肺泡巨噬细胞吸收并被
氧化爆发的产物。虽然A.烟曲霉特异性T淋巴细胞被假定在
无论是过敏性还是侵袭性曲霉病,对它们的激活、增殖、分化和功能都知之甚少。
以及吸入真菌孢子后的持久性。为了解决这个问题,我们制造了CD 4 T细胞杂交瘤,
对A.烟曲霉抗原,克隆了特异性T细胞受体的α和β链,
产生T细胞受体转基因小鼠。在这项资助申请中提出的实验将使用T细胞
受体转基因小鼠获得幼稚,A.用于转移和表征的烟曲霉特异性T细胞
感染的受体小鼠。我们有三个具体目标。第一个是研究启动和分化,
天然A.肺感染活分生孢子后的烟曲霉特异性T淋巴细胞ii_10的影响
并测定TGF-β信号对T细胞增殖和分化的影响。第二个目标是
确定A的影响。免疫功能低下患者侵袭性真菌病中的烟曲霉特异性CD 4 T细胞
或骨髓移植小鼠。我们的第三个目标是研究对真菌孢子的先天免疫反应
并确定这一过程对A.烟曲霉特异性CD 4 T细胞。我们将
首先关注MyD 88、Trif和Rip 2介导的信号。这些研究将提供一个全面的情况
T细胞对人类最普遍的机会性真菌病原体的反应,可能会打开
为对抗过敏性和侵袭性真菌疾病的新治疗干预打开了大门。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric G. Pamer其他文献
Expression and deletion analysis of the Trypanosoma brucei rhodesiense cysteine protease in Escherichia coli
布氏罗得西亚锥虫半胱氨酸蛋白酶在大肠杆菌中的表达及缺失分析
- DOI:
- 发表时间:
1991 - 期刊:
- 影响因子:3.1
- 作者:
Eric G. Pamer;C. Davis;Magdalene So - 通讯作者:
Magdalene So
Gut microbes fend off harmful bacteria by depriving them of nutrients
肠道微生物通过剥夺有害细菌的营养物质来抵御它们。
- DOI:
10.1038/d41586-024-02803-w - 发表时间:
2024-09-18 - 期刊:
- 影响因子:48.500
- 作者:
Eric G. Pamer - 通讯作者:
Eric G. Pamer
Protection against emClostridioides difficile/em disease by a naturally avirulent strain
天然无毒菌株对艰难梭菌疾病的保护作用
- DOI:
10.1016/j.chom.2024.11.003 - 发表时间:
2025-01-08 - 期刊:
- 影响因子:18.700
- 作者:
Qiwen Dong;Stephen Harper;Emma McSpadden;Sophie S. Son;Marie-Maude Allen;Huaiying Lin;Rita C. Smith;Carolyn Metcalfe;Victoria Burgo;Che Woodson;Anitha Sundararajan;Amber Rose;Mary McMillin;David Moran;Jessica Little;Michael W. Mullowney;Ashley M. Sidebottom;Louis-Charles Fortier;Aimee Shen;Eric G. Pamer - 通讯作者:
Eric G. Pamer
Immune Responses to <em>Aspergillus fumigatus</em> Infections
- DOI:
10.1016/j.bbmt.2005.09.007 - 发表时间:
2006-01-01 - 期刊:
- 影响因子:
- 作者:
Amariliz Rivera;Tobias Hohl;Eric G. Pamer - 通讯作者:
Eric G. Pamer
A spoonful of sugar could be the medicine
一勺糖可能就是良药
- DOI:
10.1038/nature23084 - 发表时间:
2017-06-14 - 期刊:
- 影响因子:48.500
- 作者:
Hea-Jin Jung;Eric G. Pamer - 通讯作者:
Eric G. Pamer
Eric G. Pamer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric G. Pamer', 18)}}的其他基金
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant Pathogens
微生物组介导的对抗生素耐药病原体的恢复力的系统生物学
- 批准号:
9922844 - 财政年份:2016
- 资助金额:
$ 43.05万 - 项目类别:
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant Pathogens
微生物组介导的对抗生素耐药病原体的恢复力的系统生物学
- 批准号:
9108539 - 财政年份:2016
- 资助金额:
$ 43.05万 - 项目类别:
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant Pathogens
微生物组介导的对抗生素耐药病原体的恢复力的系统生物学
- 批准号:
9234463 - 财政年份:2016
- 资助金额:
$ 43.05万 - 项目类别:
Innate immune defense against clostridium Difficile Infection
针对艰难梭菌感染的先天免疫防御
- 批准号:
9175987 - 财政年份:2012
- 资助金额:
$ 43.05万 - 项目类别:
Innate Immune Defense against Clostridium Difficile Infection
针对艰难梭菌感染的先天免疫防御
- 批准号:
8871670 - 财政年份:2012
- 资助金额:
$ 43.05万 - 项目类别:
Innate immune defense against clostridium Difficile Infection
针对艰难梭菌感染的先天免疫防御
- 批准号:
10055905 - 财政年份:2012
- 资助金额:
$ 43.05万 - 项目类别:
Innate Immune Defense against Clostridium Difficile Infection
针对艰难梭菌感染的先天免疫防御
- 批准号:
8369912 - 财政年份:2012
- 资助金额:
$ 43.05万 - 项目类别:
Innate Immune Defense against Clostridium Difficile Infection
针对艰难梭菌感染的先天免疫防御
- 批准号:
8495909 - 财政年份:2012
- 资助金额:
$ 43.05万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 43.05万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 43.05万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 43.05万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 43.05万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 43.05万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 43.05万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 43.05万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 43.05万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 43.05万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 43.05万 - 项目类别: